Covenant Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Hold
6,351
0.35% 32
2025
Q1
$1.33M Sell
6,351
-2,827
-31% -$592K 0.43% 27
2024
Q4
$1.63M Sell
9,178
-135
-1% -$24K 0.5% 24
2024
Q3
$1.84M Buy
9,313
+135
+1% +$26.7K 0.54% 23
2024
Q2
$1.57M Hold
9,178
0.48% 23
2024
Q1
$1.67M Hold
9,178
0.49% 23
2023
Q4
$1.42M Hold
9,178
0.45% 28
2023
Q3
$1.37M Hold
9,178
0.5% 24
2023
Q2
$1.24M Hold
9,178
0.45% 27
2023
Q1
$1.46M Hold
9,178
0.56% 18
2022
Q4
$1.48M Hold
9,178
0.6% 22
2022
Q3
$1.23M Sell
9,178
-1,761
-16% -$236K 0.6% 23
2022
Q2
$1.68M Hold
10,939
0.78% 16
2022
Q1
$1.77M Sell
10,939
-54
-0.5% -$8.75K 0.71% 18
2021
Q4
$1.49M Hold
10,993
0.55% 31
2021
Q3
$1.19M Hold
10,993
0.47% 45
2021
Q2
$1.24M Hold
10,993
0.47% 38
2021
Q1
$1.19M Sell
10,993
-1,199
-10% -$130K 0.47% 37
2020
Q4
$1.31M Buy
12,192
+630
+5% +$67.5K 0.55% 32
2020
Q3
$1.01M Sell
11,562
-620
-5% -$54.3K 0.49% 36
2020
Q2
$1.2M Buy
12,182
+396
+3% +$38.9K 0.55% 26
2020
Q1
$898K Buy
11,786
+3,354
+40% +$256K 0.48% 37
2019
Q4
$747K Buy
+8,432
New +$747K 0.35% 63
2019
Q3
Sell
-7,917
Closed -$576K 177
2019
Q2
$576K Buy
7,917
+1,593
+25% +$116K 0.31% 85
2019
Q1
$510K Buy
+6,324
New +$510K 0.28% 93